Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: A cross-sectional study

Arthritis Research and Therapy

Volumn 15, Issue 4, 2013, Pages

  Dessein, Patrick H ^a   Woodiwiss, Angela J ^a   Norton, Gavin R ^a   Solomon, Ahmed ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLOROQUINE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; RHEUMATOID ARTHRITIS; SMOKING; WAIST TO HEIGHT RATIO; BLACK PERSON; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; COMPLICATION; DEVELOPING COUNTRY; MIDDLE AGED; PREVALENCE; RISK FACTOR;

ADIPOSITY; AFRICAN CONTINENTAL ANCESTRY GROUP; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84883205040     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4276     Document Type: Article

References (81)

1. van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez-Gay MA, Smulders YM, Dijkmans BA, Nurmohamed MT. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum 2011, 40:389-397. 10.1016/j.semarthrit.2010.06.006, 20889191.
2. Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, Protogerou A, Panoulas VF, Sandoo A, Tentolouris N, Mavrikakis M, Sfikakis PP. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol 2009, 29:1702-1708. 10.1161/ATVBAHA.109.190108, 19608975.
3. Protogerou A, Zampeli E, Tentolouris N, Makrilakis K, Kitas G, Sfikakis PP. Subclinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a case-control study. Ann Rheum Dis 2012, 71:1534-1536. 10.1136/annrheumdis-2011-201278, 22764043.
4. Kaplan MJ. Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am 2010, 36:402-426.
5. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012, 71:1524-1529. 10.1136/annrheumdis-2011-200726, 22425941.
6. Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA, Nurmohamed MT. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 2009, 61:1571-1579. 10.1002/art.24836, 19877093.
7. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-1697. 10.1002/art.24092, 19035419.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702, Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
9. D'Agostino RB S, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753. 10.1161/CIRCULATIONAHA.107.699579, 18212285.
10. Romano M, Sironi M, Toniatti C, Polentanutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325. 10.1016/S1074-7613(00)80334-9, 9075932.
11. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999, 19:972-978. 10.1161/01.ATV.19.4.972, 10195925.
12. Ridker PM, Rifai N, Stempfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772. 10.1161/01.CIR.101.15.1767, 10769275.
13. Verma S, Li S-H, Badiwala MV, Weisel RD, Fedak PW, Li R-K, Dhillon B, Mickle DA. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896. 10.1161/01.CIR.0000015126.83143.B4, 11997273.
14. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003, 107:391-397. 10.1161/01.CIR.0000055014.62083.05, 12551861.
15. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J Hypertens 2003, 21:1787-1803. 10.1097/00004872-200310000-00002, 14508181.
16. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention; American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511. 10.1161/01.CIR.0000052939.59093.45, 12551878, Centers for Disease Control and Prevention; American Heart Association.
17. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812. 161431, 12813013.
18. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695. 10.1056/NEJMra043430, 15843671.
19. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007, 49:2129-2138. 10.1016/j.jacc.2007.02.052, 17531663.
20. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003, 108:2957-2963. 10.1161/01.CIR.0000099844.31524.05, 14676136.
21. Dessein PH, Joffe BI, Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R634-R643. 10.1186/ar1717, 1174955, 15899050.
22. Dessein PH, Norton GR, Woodiwiss AJ, Joffe BI, Solomon A. Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. J Rheumatol 2007, 34:681-688.
23. Rodriguez-Rodriguez L, Gonzalez-Juanatey C, Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011, 216:125-130. 10.1016/j.atherosclerosis.2010.10.052, 21420089.
24. Rodriguez-Rodriguez L, Gonzalez-Juanatey C, Garcia-Bermudez M, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther 2011, 13:R133. 10.1186/ar3444, 3239375, 21846359.
25. Teruel M, Martin JE, Gonzalez-Juanatey C, Lopez-Mejias R, Miranda-Filloy JA, Blanco R, Balsa A, Pascual-Salcedo D, Rodriguez-Rodriguez L, Fernandez-Gutierrez B, Ortiz AM, Gonzalez-Alvaro I, Gomez-Vaquero C, Bottini N, Llorca J, Gonzalez-Gay MA, Martin J. Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. Arthritis Res Ther 2011, 13:R116. 10.1186/ar3401, 3239354, 21767392.
26. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007, 57:125-132. 10.1002/art.22482, 17266100.
27. Toms TE, Panoulas VF, Smith JP, Douglas KM, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Ann Rheum Dis 2011, 70:1025-1032. 10.1136/ard.2010.144634, 21398331.
28. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004, 50:3444-3449. 10.1002/art.20636, 15529391.
29. del Rincon I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 48:1833-1840. 10.1002/art.11078, 12847676.
30. Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 2011, 70:8-14. 10.1136/ard.2010.142133, 21109513.
31. Gabriel SE. Heart disease and rheumatoid arthritis: understanding the risks. Ann Rheum Dis 2010, 69:(Suppl 1):61-64.
32. Dessein PH, Stanwix AE, Joffe BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002, 4:R5. 10.1186/ar428, 125299, 12223108.
33. Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006, 54:2765-2775. 10.1002/art.22053, 16947779.
34. Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis. Joint Bone Spine 2011, 78:179-183. 10.1016/j.jbspin.2010.07.016, 20851020.
35. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology 2004, 43:1219-1223. 10.1093/rheumatology/keh321, 15292530.
36. Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol 2010, 6:445-451. 10.1038/nrrheum.2010.105, 20647995.
37. Giles JT, Allison M, Blumenthal RS, Post W, Petri M, Tracy R, Szklo M, Bathon JM. Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 2010, 62:3173-3182. 10.1002/art.27629, 2962724, 20589684.
38. Solomon A, Norton GR, Woodiwiss AJ, Dessein PH. Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2012, 14:R67. 10.1186/ar3784, 3446436, 22430029.
39. Dessein PH, Joffe BI. Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis. Clin Exp Rheumatol 2006, 24:161-167.
40. Dessein PH, Joffe BI, Stanwix AE, Christian BF, Veller M. Glucocorticoids and insulin sensitivity in rheumatoid arthritis. J Rheumatol 2004, 31:867-874.
41. del Rincon I, O'Leary DH, Haas RW, Escalante A. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 2004, 50:3813-3822. 10.1002/art.20661, 15593231.
42. Ruyssen-Witrand A, Fautrel B, Saraux A, Le Loet X, Pham T. Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine 2011, 78:23-30. 10.1016/j.jbspin.2010.02.040, 20471897.
43. Munro R, Morrison E, McDonald AG, Hunter JA, Madhok R, Capell HA. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis 1997, 56:374-377. 10.1136/ard.56.6.374, 1752398, 9227167.
44. Dessein PH, Christian BF, Solomon A. Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context?. J Rheumatol 2009, 36:1357-1361. 10.3899/jrheum.090288, 19567631.
45. Wasko MC, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, Ward MM. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 2007, 298:187-193. 10.1001/jama.298.2.187, 17622600.
46. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, Kitas GD. Hypertension in rheumatoid arthritis. Rheumatology 2008, 47:1286-1298. 10.1093/rheumatology/ken159, 18467370.
47. Laborde F, Loeuille D, Chary-Valckenaere I. Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis. Arthritis Rheum 2004, 50:3398.
48. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952. 10.1016/S0140-6736(04)17018-9, 15364185, INTERHEART Study Investigators.
49. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part 1: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001, 104:2746-2753. 10.1161/hc4601.099487, 11723030.
50. Solomon A, Christian BF, Norton GR, Woodiwiss AJ, Dessein PH. Risk factor profiles for atherosclerotic cardiovascular disease in black and other Africans with established rheumatoid arthritis. J Rheumatol 2010, 37:953-960. 10.3899/jrheum.091032, 20231201.
51. Dessein PH, Norton GR, Joffe BI, Abdool-Carrim AT, Woodiwiss AJ, Solomon A. Metabolic cardiovascular risk burden and atherosclerosis in African black and Caucasian women with rheumatoid arthritis: a cross-sectional study. Clin Exp Rheumatol 2013, 31:53-61.
52. Solomon A, Woodiwiss AJ, Abdool-Carrim AT, Stevens BA, Norton GR, Dessein PH. The carotid artery atherosclerosis burden and its relation to cardiovascular risk factors in black and white Africans with established rheumatoid arthritis: a cross-sectional study. J Rheumatol 2012, 39:1798-1806. 10.3899/jrheum.120073, 22753659.
53. Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V, Mbanaga N. Obesity in South Africa: the South African Demographic and Health Survey. Obes Res 2002, 10:1038-1048. 10.1038/oby.2002.141, 12376585.
54. Opie LH, Seeadat YK. Hypertension in Sub-Saharan African populations. Circulation 2005, 112:3562-3568. 10.1161/CIRCULATIONAHA.105.539569, 16330697.
55. Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan NT, Malan L, Mels CM, Smith W, Moss SJ, Towers GW, Kruger HS, Wentzel-Viljoen E, Vorster HH, Kruger A. Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study. Int J Epidemiol 2012, 41:1114-1123. 10.1093/ije/dys106, 22825590.
56. Redelinghuys M, Norton GR, Janse van Rensburg NM, Maseko MJ, Majane OH, Dessein P, Woodiwiss AJ. Lack of independent association between C-reactive protein and central aortic hemodynamics in black Africans with high risk of cardiovascular disease. Am J Hypertens 2011, 24:1094-1101. 10.1038/ajh.2011.119, 21753803.
57. Schutte AE, van Vuuren D, van Rooyen JM, Huisman HW, Schutte R, Malan L, Malan NT. Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study. J Hum Hypertens 2006, 20:850-859. 10.1038/sj.jhh.1002065, 16855625.
58. Phulukdaree A, Khan S, Ramkaran P, Govender R, Moodley D, Chuturgoon AA. The interleukin-6 -147 g/c polymorphism is associated with increased risk of coronary artery disease in young South African Indian men. Metab Syndr Relat Disord 2013, 11:205-209. 10.1089/met.2012.0130, 23461479.
59. Norton GR, Maseko M, Libhaber E, Libhaber CD, Majane OH, Dessein P, Sareli P, Woodiwiss AJ. Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent?. J Hypertens 2008, 26:2279-2287. 10.1097/HJH.0b013e328311f296, 19008706.
60. Woodiwiss AJ, Molebatsi N, Maseko MJ, Libhaber E, Libhaber C, Majane OH, Paiker J, Dessein P, Brooksbank R, Sareli P, Norton GR. Nurse-recorded auscultatory blood pressure at a single visit predicts target organ changes as well as ambulatory blood pressure. J Hypertens 2009, 27:287-297. 10.1097/HJH.0b013e328317a78f, 19155786.
61. Norton GR, Majane OH, Maseko MJ, Libhaber C, Redelinghuys M, Kruger D, Veller M, Sareli P, Woodiwiss AJ. Brachial blood pressure-independent relations between radial late systolic shoulder-derived aortic pressures and target organ changes. Hypertension 2012, 59:885-892. 10.1161/HYPERTENSIONAHA.111.187062, 22331378.
62. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
63. Gulfe A, Aletaha D, Saxne T, Geborek P. Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents. BMC Musculoskelet Disord 2009, 10:41. 10.1186/1471-2474-10-41, 2678269, 19389230.
64. Gepner AD, Korcarz CE, Aeschlimann SE, LeCaire TJ, Palta M, Tzou WS, Stein JH. Validation of a carotid intima-media thickness border detection program for use in an office setting. J Am Soc Echocardiogr 2006, 19:223-228. 10.1016/j.echo.2005.09.006, 16455429.
65. Ness RB, Haggerty CL, Harger G, Ferrell R. Differential distribution of allelic variants in cytokine genes among African Americans and white Americans. Am J Epidemiol 2004, 160:1033-1038. 10.1093/aje/kwh325, 15561982.
66. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991, 13:267-276.
67. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003, 34:2922-2929. 10.1161/01.STR.0000099124.84425.BB, 14605324.
68. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J Am Coll Cardiol 2000, 35:714-721. 10.1016/S0735-1097(99)00594-X, 10716475.
69. Chikanza IC, Stein M, Lutalo S, Gibson T. The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patients. J Rheumatol 1994, 32:2011-2015.
70. Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, Woodworth T, Gomez-Reino JJ. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs. Arthritis Rheum 2008, 58:2968-2980. 10.1002/art.23940, 18821691.
71. Dessein PH, Tobias M, Veller MG. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 2006, 33:2425-2432.
72. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008, 196:758-763.
73. Westhovens R, Nijs J, Taelman V, Dequeker J. Body composition in rheumatoid arthritis. Br J Rheumatol 1997, 36:444-448. 10.1093/rheumatology/36.4.444, 9159537.
74. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, Muller D, Fontaine KR, Bathon JM. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008, 59:807-815. 10.1002/art.23719, 2670994, 18512711.
75. Hassinen M, Lakka TA, Komulainen P, Haapala I, Nissinen A, Rauramaa R. Association of waist and hip circumference with 12-year progression of carotid intima-media thickness in elderly women. Int J Obes 2007, 31:1406-1411.
76. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent association of hip circumference with metabolic profile in different ethnic groups. Obes Res 2004, 12:1370-1374. 10.1038/oby.2004.173, 15483201.
77. Dessein PH, Joffe BI, Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 2004, 6:443-446.
78. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009, 38:366-371. 10.1016/j.semarthrit.2008.01.012, 18336869.
79. Evans MR, Escalante A, Battafarano DF, Freeman GL, O'Leary DH, del Rincon I. Carotid atherosclerosis predicts incident acute coronary syndrome in rheumatoid arthritis. Arthritis Rheum 2011, 63:1211-1220. 10.1002/art.30265, 3286362, 21305526.
80. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2010, 56:e50-103. 10.1016/j.jacc.2010.09.001, 21144964.
81. Peters SA, den Ruijter HM, Bots ML, Moons KG. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012, 98:177-184. 10.1136/heartjnl-2011-300747, 22095617.